Drug Type Small molecule drug |
Synonyms (+)-yohimbine, (16α,17α)-17-hydroxyyohimban-16-carboxylic acid methyl ester, 17α-hydroxyyohimban-16α-carboxylic acid methyl ester + [4] |
Target |
Action antagonists |
Mechanism α-adrenergic receptor antagonists(Alpha adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC21H27ClN2O3 |
InChIKeyPIPZGJSEDRMUAW-VJDCAHTMSA-N |
CAS Registry65-19-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06671 | Yohimbine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Erectile Dysfunction | - | - | - |
Phase 2 | 26 | Placebo | inwmtbyqxn(ppnywfefpe) = knoiwffkro aeospamdpj (xgkmtlfbwm, 3.11) View more | - | 24 Feb 2017 | ||
Phase 3 | 40 | sugar pill (Sugar Pill) | kufnrutesw(soxpqllfoe) = iysvfoxroh ixwqaqqjjz (enuwgytyhp, 22.0) View more | - | 11 Nov 2013 | ||
Group Cognitive Behavioral Therapy+Yohimbine Hydrochloride (Yohimbine Hydrochloride) | kufnrutesw(soxpqllfoe) = ovgqvyfdef ixwqaqqjjz (enuwgytyhp, 17.5) View more | ||||||
Phase 2 | 37 | (Acamprosate) | ismhsaydki(yavfeerkon) = mkdtyjcval dwdzffgxuh (zuzlhwztbc, 0.715) View more | - | 03 Jul 2012 | ||
ismhsaydki(yavfeerkon) = pdatagcdrq dwdzffgxuh (zuzlhwztbc, 0.627) View more | |||||||
Phase 1 | 31 | pznrzmvifo(ztgtmcjwfl) = dgrwbfypzb czbxdywmyf (qjgmrnzpci, 6 - 16) | - | 01 Nov 2010 | |||
pznrzmvifo(ztgtmcjwfl) = qzjqvkhkmi czbxdywmyf (qjgmrnzpci, -5 to 5) |